LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

Search

Champions Oncology Inc

Fermé

SecteurSoins de santé

6.26 1.29

Résumé

Variation du prix de l'action

24h

Actuel

Min

5.45

Max

6.41

Chiffres clés

By Trading Economics

Revenu

-514K

-278K

Ventes

1.5M

17M

P/E

Moyenne du Secteur

35.118

50.958

BPA

-0.02

Marge bénéficiaire

-1.679

Employés

213

EBITDA

-508K

104K

Dividendes

By Acuity

Prochains Résultats

22 juil. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

3.9M

87M

Ouverture précédente

4.97

Clôture précédente

6.26

Sentiment de l'Actualité

By Acuity

100%

0%

323 / 342 Classement par Healthcare

Champions Oncology Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

À Propos Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat